dabigatran has been researched along with Rhabdomyolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Liu, L; Zhang, Z; Zheng, T | 1 |
| Bykov, K; Gagne, JJ; Glynn, RJ; Mittleman, MA; Schneeweiss, S | 1 |
2 other study(ies) available for dabigatran and Rhabdomyolysis
| Article | Year |
|---|---|
Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report.
Topics: Aged, 80 and over; Benzimidazoles; Dabigatran; Female; Humans; Muscle Weakness; Pyridines; Rhabdomyolysis | 2022 |
A Case-Crossover-Based Screening Approach to Identifying Clinically Relevant Drug-Drug Interactions in Electronic Healthcare Data.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Cross-Over Studies; Cytochrome P-450 CYP3A; Dabigatran; Drug Interactions; Electronic Health Records; Female; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis | 2019 |